In June, Dermira Inc. announced the FDA approval of Qbrexza (glycopyrronium) for primary axillary hyperhidrosis ― excessive underarm sweating.
The U.S. landscape of neuromodulators, which play well with other aesthetic treatments, continues to expand, said experts at The Cosmetic Bootcamp.
Options include a new FDA-approved topical, injections and energy. Dee Anna Glaser, M.D., shares patient profiles and use considerations for each.
Not everyone’s ideal vacation involves lounging on a beach or schlepping through amusement parks. Each year, millions of travelers around the world seek out trips that offer more than adventure through voluntourism.
Superficial chemical peels have a relatively low complication rate in patients with darker skin types when performed appropriately, a study finds.
New scientific research suggests that the scalp aging may closely parallel facial skin aging and maintaining healthy hair requires preventive care for both the follicle and surrounding tissue.
The foundation of skincare, aesthetics and dermatology relies on the practitioner's ability to effectively work with the skin barrier. Understanding what it is, how it behaves, as well as how to improve and repair it, is critical to implementing any treatment plan. Unfortunately, many dermatologists and other specialists find it difficult to explain the skin barrier to patients in simple terms.
Dermatologists have always known that different ethnic skin types age at different rates, but until now there hasn’t been clear evidence that these phenotypic differences have a pathophysiologic and histologic basis.
Spanish researchers have developed a scoring system to assess the severity of frontal fibrosing alopecia, a scarring form of alopecia marked by hairline recession and eyebrow loss primarily affecting postmenopausal women.
A new accelerator fund for skin treatments is designed to bridge the gap between institutional research funding and traditional venture capital, providing a structure and path forward for entrepreneurs, researchers and clinicians.